Tag: Prescription Drugs
Dapagliflozin May Be Cost-Effective for Treating CKD
Dapagliflozin for the treatment of chronic kidney disease cost-effective at willingness-to-pay thresholds of $27,510 and $35,503 per QALY in U.K. and Germany, Spain
Once-Weekly Semaglutide Cuts BMI for Teens With Obesity
Greater reduction in BMI seen for semaglutide plus lifestyle intervention versus lifestyle intervention alone
Brentuximab Vedotin + Chemo Ups Event-Free Survival in Peds Hodgkin Lymphoma
Event-free survival rate higher in pediatric patients, but no difference seen in the percentage of patients receiving involved-site radiation therapy
Telehealth Tied to Higher Buprenorphine Retention
Substantial number of Veterans Health Administration patients received buprenorphine from phone-only telehealth
Neoadjuvant Combo Immunotherapy Studied in Resectable Melanoma
In phase 2 study, relatlimab and nivolumab combination immunotherapy resulted in pathologic complete response rate of 57 percent
Haloperidol Not Beneficial for ICU Patients With Delirium
No improvement seen in number of days alive and out of the hospital at 90 days for haloperidol versus placebo
Many Parents Have Unused Prescription Meds at Home
Authors say proper disposal of unused medications is important to protect children and the environment
Disparities ID’d in Dispensing of Oral Antivirals for COVID-19
Substantial disparities seen in dispensing rates in high social-vulnerability zip codes versus medium-, low-vulnerability zip codes
IDSA: Long-Term Follow-Up Reported for Early Initiation of ART in HIV
Excess risk for AIDS, serious non-AIDS conditions, death for those deferring treatment reduced soon after initiation of ART
Nivolumab Promising for Treatment of Advanced Cutaneous SCC
Robust antitumor activity and good tolerability observed in phase 2 study of nivolumab for first-line treatment of advanced cutaneous squamous cell carcinoma
